Cts (CTS) EBITDA (2010 - 2026)

Cts (CTS) has reported EBITDA for 17 consecutive years, with $26.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA rose 17.91% year-over-year to $26.8 million; the trailing twelve-month figure through Jun 2026 stood at $92.4 million (up 18.62% YoY), and the FY2025 full-year result was $82.6 million, up 16.09% from the prior year.
• EBITDA climbed to $26.8 million in Q2 2026 per CTS's latest filing, from $22.0 million in the prior quarter.
• Across five years, EBITDA topped out at $26.8 million in Q2 2026 and bottomed at $14.5 million in Q1 2024.
• Historically, EBITDA has averaged $20.6 million across 5 years, with a median of $21.3 million in 2022.
• The sharpest annual moves came in 2022 and 2024: EBITDA jumped 40.8% in 2022, then slumped 34.45% in 2024.
• Over 5 years, EBITDA stood at $21.6 million in 2022, then retreated by 24.85% to $16.3 million in 2023, then grew by 10.78% to $18.0 million in 2024, then rose by 25.98% to $22.7 million in 2025, then gained by 18.13% to $26.8 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $26.8 million, $22.0 million, and $22.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.